Dr. Kozuch on the Evaluation of ctDNA in the CIRCULATE-US Trial in Resected CRC
Peter Kozuch, MD, discusses the phase 2/3 CIRCULATE-US trial evaluating chemotherapy decisions for patients with resected colorectal cancer based on circulating tumor DNA status.